HIGHLIGHTS
- who: Boyu Chi and colleagues from the Department of Cardiology, The Affiliated Changzhou No, People`s Hospital of Nanjing Medical University, Changzhou, Jiangsu, China have published the article: Empagliflozin-Pretreated Mesenchymal Stem Cell-Derived Small Extracellular Vesicles Attenuated Heart Injury, in the Journal: Oxidative Medicine and Cellular Longevity of 18/02/2023
- what: The authors investigated the cardioprotective effects of EMPA-pretreated MSC-derived small extracellular vesicles in_vitro and in_vivo. Based on the results of miRNA target gene KEGG analysis, the authors focused on the AKT signaling pathway. This study has several major findings. Based . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.